Compile Data Set for Download or QSAR
Report error Found 6 Enz. Inhib. hit(s) with all data for entry = 7793
TargetSodium-dependent noradrenaline transporter(Human)
Drexel University

US Patent
LigandPNGBDBM218671(US9289400, ES609)
Affinity DataIC50: 293nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2017
Entry Details
Go to US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Drexel University

US Patent
LigandPNGBDBM218672(US9289400, PBZI)
Affinity DataIC50: 860nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2017
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Human)
Drexel University

US Patent
LigandPNGBDBM218672(US9289400, PBZI)
Affinity DataIC50: 1.61E+3nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2017
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Human)
Drexel University

US Patent
LigandPNGBDBM218671(US9289400, ES609)
Affinity DataIC50: 8.52E+3nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2017
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Drexel University

US Patent
LigandPNGBDBM218672(US9289400, PBZI)
Affinity DataIC50: 1.38E+4nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2017
Entry Details
Go to US Patent

TargetSodium-dependent serotonin transporter(Human)
Drexel University

US Patent
LigandPNGBDBM218671(US9289400, ES609)
Affinity DataIC50: 3.59E+4nMAssay Description:Functional efficacy was determined by assessing the ability of PBZI and ES609 to inhibit monoamine transporter uptake activity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2017
Entry Details
Go to US Patent